Healio

VIDEO: Subcutaneous injection shows promise for wet AMD, DME

Please provide your email address to receive an email when new articles are posted on . FORT LAUDERDALE, Fla. — In this Healio Video Perspective, Michael A. Singer, MD, discusses promising results for ...
Nasdaq

Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting

ALPHARETTA, Ga., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
MedPage Today

AAO Poster Roundup: AMD Natural History; Treat and Extend; Longer Injection Intervals

NEW ORLEANS -- Two poster sessions that spanned 4 days of the American Academy of Ophthalmology meeting provided new data about the natural history and management of age-related macular degeneration ...
BioWorld

4DMT’s one-shot gene therapy cuts anti-VEGF injections in severe wet AMD patients

4DMT Molecular Therapeutics Inc. is looking ahead to phase III as positive data continue to roll out for gene therapy candidate 4D-150 in wet age-related macular degeneration (AMD), with the results ...
The American Journal of Managed Care

Finding Ways to Avoid Injection Treatment Could Be Next Step in Approach to AMD: Julie Rosenthal, MD, MS

Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration. In the second part of her Q&A with The American Journal of Managed Care ®, Julie ...
FOX31 Denver

Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single Intravitreal Injection of Ixo-vec ...

- Data demonstrating that Ixo-vec was generally well tolerated and that a single intravitreal (IVT) injection can lead to stable and persistent aflibercept protein levels through three years in ...